Serina Therapeutics Director Karen Wilson Acquires Additional Shares Amid Executive Restructuring
Karen J. Wilson, a director at Serina Therapeutics, Inc. (NASDAQ:SER), has increased her stake in the company through recent common stock purchases. These transactions are documented in a Form 4 filing submitted to the Securities and Exchange Commission on June 15, 2026, covering activity on June 11 and June 12. Concurrently, Serina Therapeutics an…